Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05197621 · ClinicalTrials.gov registry record
The Impact of COVID-19 on Maternal and Neonatal Outcomes
A clinical trial of COVID-19 and Pregnancy; Infection, sponsored by Johns Hopkins University.
- Recruiting
- Registry status
- 300
- Enrollment target
- 1
- Study location
NCT05197621 is a study of COVID-19 and Pregnancy; Infection that is actively recruiting participants, run by Johns Hopkins University. The registered enrollment target is 300 participants, below the 55,213-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05197621, a study of COVID-19 and Pregnancy; Infection, is actively recruiting participants, sponsored by Johns Hopkins University.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 1
- Study location
Study Summary
The novel coronavirus (SARS-CoV-2) infection (COVID-19) has caused a worldwide pandemic. There is still much that is unknown regarding the virus, especially its effects on pregnancy, the fetus, and the neonate. This study seeks to evaluate adverse pregnancy and neonatal outcomes related to COVID-19 infection. The FDA has authorized emergency use authorization for the SARS-CoV-2 messenger ribonucleic acid (mRNA) vaccines from Pfizer and Moderna. Pregnant women were excluded from the Phase III clinical trials of the mRNA vaccines. There are no studies that have evaluated functional antibody responses, antibody reactivity to variant viruses, T cell frequencies or activity, or protection against infection or development of COVID-19. Having a more detailed understanding of how pregnancy and lactation alters the longevity, specificity, and activity of antiviral antibody and T cell-mediated immune responses to COVID-19 mRNA vaccines is essential for the FDA to inform future recommendations and regulation of these vaccines.
Conditions Studied
Interventions
- BIOLOGICAL mRNA COVID-19 vaccine (Pfizer or Moderna)
Study Locations (1)
Maryland
- Johns Hopkins Hospital - Baltimore
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2020-04-13 |
| Est. Completion | 2028-05-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05197621
The ClinicalTrials.gov registry entry for NCT05197621 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 55,213-participant average among 203 other COVID-19 trials with a reported enrollment target (99% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with COVID-19 appearing as the primary indexed condition, and to 1 intervention - of which mRNA COVID-19 vaccine (Pfizer or Moderna) is the first listed.
NCT05197621 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.
Frequently Asked Questions
What is clinical trial NCT05197621 about?
NCT05197621 is a clinical study titled "The Impact of COVID-19 on Maternal and Neonatal Outcomes". The novel coronavirus (SARS-CoV-2) infection (COVID-19) has caused a worldwide pandemic. There is still much that is unknown regarding the virus, especially its effects on pregnancy, the fetus, and the neonate. This study seeks to evaluate adverse pregnancy and neonatal outcomes related to COVID-19 ...
What is the current status of trial NCT05197621?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2020-04-13. Estimated completion is 2028-05-05.
What conditions does trial NCT05197621 study?
This clinical trial studies the following conditions: COVID-19, Pregnancy; Infection.
What interventions are being tested in trial NCT05197621?
The interventions under investigation include: mRNA COVID-19 vaccine (Pfizer or Moderna) (BIOLOGICAL).
Who is sponsoring clinical trial NCT05197621?
This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05197621 being conducted?
This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for COVID-19
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19
RECRUITING · NA
-
Arginine Replacement Therapy in COVID-19
RECRUITING · Phase 2
-
A Study to Learn About Variant-Adapted COVID-19 RNA Vaccine Candidate(s) in Healthy Children
RECRUITING · Phase 2
-
Cardiac Magnetic Resonance Tissue Characterization in COVID-19 Survivors
RECRUITING
-
COVID-19 Health Adjustments in Nutrition, General Wellness, and Exercise
RECRUITING
-
Music Mindfulness Study 2a.
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.